Similarly, knockout of HPK1 or inhibition of HPK1 kinase activity using small-molecular inhibitors has also been shown to enhance T cell antitumor functions and to inhibit tumor growth in syngeneic allograft mouse models (19, 22, 23). Here, MAP4K1 is linked to neoplasm.